- industrial
- pharma
Buprenorphine
CAS 52485-79-7
Also registered as 1 other CAS number
22152-15-4
Concern score
Not assessed — no hazard data yet.
Buprenorphine in plain language
Also known as Buprenorphin · Brixadi · Butrans · Bupeaze · Buplast · Buprenophine
Show all 20 names
Buprenorfine · Buprenorphinum · CAM2038 · Hapoctasin · Probuphine · Panitaz · Prenotrix · Sublocade · Suboxone · Subutex · Temgesic · Transtec · buprenorfina · ALKS-5461 component buprenorphine
We don't have a plain-language description for Buprenorphine yet.
Recorded functional uses: Pharmaceutical
- We haven't assessed a concern score for this ingredient yet.
Regulation
No restrictions found. Buprenorphine appears in these published regulatory listings.
- In marketed US drugs
- Found in consumer products
- Industrial
USEPAcommercial use observedEPA CPDat observed this chemical in 0 composition records across product categories including unclassified products. EPA CPDat classifies this chemical for functional uses including Pharmaceutical.
- EPA CPDat observed this chemical in 0 composition records across product categories including unclassified products. EPA CPDat classifies this chemical for functional uses including Pharmaceutical.Source →
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 44 active drug products and 48 total products.
- FDA NDC lists this ingredient in 44 active drug products and 48 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Evidence & sources
No graded research studies for Buprenorphine yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Where this comes from
- Open →
EPA Chemical and Products Database
exposure · updated September 2018
- Open →
EPA DSSTox Identifiers
chemistry · updated 2025-12-29
- Open →
FDA National Drug Code Directory
regulatory · updated 2027-12-31
- Open →
FDA GSRS UNII
registry · updated 2026-02-26
- Open →
openFDA Substance
registry · updated 2026-05-24
- Open →
PubChem Live Enrichment
chemistry · updated 2026-05-17
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
Where it has been recorded
How often FDA National Drug Code directory has listed Buprenorphine in a product composition. These are source records, not Greenveil catalog products.
Source records
48
Typical roles
Pharmaceutical